Management of Postpartum Hemorrhage

Definition and Diagnosis

• Postpartum hemorrhage (PPH) is defined as blood loss of more than 500 mL after vaginal birth or 1000 mL after caesarean section, or any blood loss sufficient to compromise hemodynamic stability 1

First-Line Management

• The American College of Obstetricians and Gynecologists recommends administering oxytocin 5-10 IU slow IV or intramuscular injection immediately postpartum, alongside fluid resuscitation with physiologic electrolyte solutions and implementation of uterine massage and bimanual compression as immediate non-pharmacological interventions 1
• Monitoring of vital signs is crucial to assess response to treatment 1

Tranexamic Acid Administration

• The World Health Organization recommends administering tranexamic acid (TXA) 1 g (100 mg/mL) intravenously at 1 mL/min (over 10 minutes) within 3 hours of birth, as delay reduces benefit by approximately 10% for every 15 minutes 1, 2
• A second dose of 1 g should be administered if bleeding continues after 30 minutes or restarts within 24 hours, but TXA is contraindicated in women with a known thromboembolic event during pregnancy 1, 2, 3

Non-Surgical Interventions

• Intrauterine balloon tamponade can be implemented if pharmacological management fails, and non-pneumatic antishock garment can be used for temporary stabilization while arranging definitive care 1

Surgical Interventions

• Surgical interventions, including uterine compression sutures, uterine or internal iliac artery ligation, and hysterectomy, should be considered if bleeding continues despite medical management and non-surgical approaches 1

Specific Management Based on Etiology

• The American College of Radiology recommends addressing uterine rupture or inversion in cases of trauma 4
• Manual removal of retained placenta or surgical evacuation of retained products of conception can be performed in cases of tissue-related PPH 1

Imaging Considerations

• Ultrasound can help diagnose retained products of conception, showing an echogenic endometrial mass with vascularity 5
• CT with IV contrast can be useful in hemodynamically stable patients to localize bleeding sources, particularly for intra-abdominal hemorrhage 4, 6

Common Pitfalls and Considerations

• Delay in TXA administration significantly reduces its effectiveness, with a 10% reduction in benefit for every 15 minutes of delay 1, 2
• Small (<4 cm) subfascial and bladder flap hematomas may not be clinically significant 4
• Methylergonovine is contraindicated in patients with hypertension due to risk of vasoconstriction 1
• Continue hemodynamic monitoring for at least 24 hours after delivery, as this period has significant hemodynamic changes 1

Management of Postpartum Hemorrhage

Initial Assessment and Management

• Obtain baseline laboratory tests, including complete blood count, coagulation profile, and crossmatch for blood products, as recommended by the American College of Obstetricians and Gynecologists 7
• Maintain patient warmth, as clotting factors function poorly at lower temperatures, according to the American College of Obstetricians and Gynecologists 7, 8

Transfusion and Intervention

• Initiate massive transfusion protocol if blood loss exceeds 1500 mL, and transfuse packed red blood cells, fresh frozen plasma, and platelets in a fixed ratio, as recommended by the American College of Obstetricians and Gynecologists 7
• Consider interventional radiology for arterial embolization, particularly when no single source of bleeding can be identified, according to the American College of Obstetricians and Gynecologists 7, 9

Surgical Management

• Pelvic pressure packing can be effective for patient stabilization when experiencing acute uncontrolled hemorrhage, and may be left in for 24 hours, as recommended by the American College of Obstetricians and Gynecologists 7, 9
• Systematic pelvic devascularization, including uterine or internal iliac artery ligation, may be considered as a last resort, according to the American College of Obstetricians and Gynecologists 9

Post-Acute Management

• Monitor for complications, including renal failure, liver failure, infection, and Sheehan syndrome, as recommended by the American College of Obstetricians and Gynecologists 8
• Re-dose prophylactic antibiotics if blood loss exceeds 1500 mL, according to the American College of Obstetricians and Gynecologists 7

Common Pitfalls to Avoid

• Delaying treatment for active hemorrhage while waiting for laboratory results is not recommended, as stated by the American College of Obstetricians and Gynecologists 7
• Failing to maintain normothermia and normal pH can impair clotting, according to the American College of Obstetricians and Gynecologists 7, 8

Bimanual Uterine Tamponade Technique

Clinical Application

• The standard technique for bimanual uterine tamponade involves one provider placing a fist inside the vagina against the anterior lower uterine segment and simultaneously applying counter-pressure with the other hand on the abdomen, while assessing for cervical motion tenderness, which may indicate pelvic infection 10

Immediate Management of Postpartum Hemorrhage – Evidence‑Based Guideline Summary

Team Activation and Initial Resuscitation

• Activate a massive hemorrhage protocol with a designated team leader to coordinate all interventions in postpartum hemorrhage (Anaesthesia guidelines, 2010) 11
• Assign dedicated roles – a communications lead for laboratory coordination, a member for blood‑product transport, and a clinician responsible for securing large‑bore vascular access (Anaesthesia guidelines, 2010) 12
• Establish large‑bore intravenous access immediately (≥8‑Fr central line in adults); if peripheral attempts fail, use intra‑osseous or surgical access (Anaesthesia guidelines, 2010) 11
• Provide high‑flow oxygen to maintain tissue perfusion (Anaesthesia guidelines, 2010) 12

Blood‑Loss Measurement and Laboratory Assessment

• Place a calibrated collection bag at delivery to obtain accurate cumulative blood‑loss measurement (Anaesthesia 2025) 13
• Obtain baseline labs urgently: complete blood count, PT, aPTT, Clauss fibrinogen, and cross‑match for at least 4–6 units of packed red cells (Anaesthesia guidelines, 2010) 11
• Use point‑of‑care viscoelastic testing (TEG/ROTEM) when available to guide coagulation management (Anaesthesia guidelines, 2010) 12
• Do not rely on derived fibrinogen values; only Clauss fibrinogen provides accurate measurement (Anaesthesia guidelines, 2010) 11

Fluid Resuscitation and Temperature Management

• Begin aggressive resuscitation with warmed physiologic electrolyte solutions (Anaesthesia guidelines, 2010) 12
• Actively warm the patient and all transfused fluids; maintain core temperature > 36 °C to preserve clotting factor activity (Anaesthesia guidelines, 2010) 11

Pharmacologic Hemorrhage Control

• Administer tranexamic acid 1 g IV over 10 min within 3 h of delivery; effectiveness declines ≈10 % for every 15 min delay (Anaesthesia 2025; high‑quality international trial data) 13
• Tranexamic acid has been shown to reduce bleeding‑related mortality and progression to severe postpartum hemorrhage (Anaesthesia 2025; high‑quality trial evidence) 13

Blood‑Product Strategy

• For severe ongoing bleeding, transfuse in a 4 : 4 : 1 ratio (RBC : FFP : platelets) or a 1 : 1 : 1 ratio according to institutional protocol (Anaesthesia 2025) 13
• Do not give fresh‑frozen plasma routinely in obstetric postpartum hemorrhage; withhold until ≥4 units of RBCs have been transfused unless early coagulopathy is documented (Anaesthesia 2025) 13

Fibrinogen Management

• Hypofibrinogenemia (Clauss fibrinogen < 2 g/L) occurs in ~17 % of postpartum hemorrhage cases with blood loss > 2 500 mL and is the most common factor deficiency (Anaesthesia 2025) 13
• A fibrinogen level < 3 g/L (especially < 2 g/L) predicts progression to massive obstetric hemorrhage (Anaesthesia 2025) 13
• Give cryoprecipitate or fibrinogen concentrate early when fibrinogen is < 2–3 g/L with ongoing bleeding; in early severe hypofibrinogenemia (e.g., placental abruption, amniotic‑fluid embolus, sepsis with pre‑eclampsia) it may be administered before red cells (Anaesthesia 2025) 13
• Platelet transfusion is rarely required unless blood loss > 5 000 mL or platelet count < 75 × 10⁹/L (Anaesthesia 2025) 13

Ongoing Monitoring

• Continuously monitor vital signs (heart rate, blood pressure, capillary refill, level of consciousness, skin color) during postpartum hemorrhage (Anaesthesia guidelines, 2010) 11
• Observe visible external blood loss (floor, drains, clothing) and assess for signs of internal bleeding (Anaesthesia guidelines, 2010) 12

Tranexamic Acid Administration and Immediate Resuscitation in Post‑partum Hemorrhage

Pharmacologic Intervention

• Administer tranexamic acid 1 g IV over 10 minutes (≈1 mL/min) as soon as postpartum hemorrhage is diagnosed and within 3 hours of delivery; this reduces bleeding‑related mortality when combined with oxytocin and aggressive resuscitation. [@1]
• Effectiveness of tranexamic acid declines by ~10 % for every 15‑minute delay in administration; no mortality benefit is observed if given after 3 hours. [@1]
• A second 1 g dose of tranexamic acid may be given if bleeding persists after 30 minutes or recurs within 24 hours. [@4]

Immediate Resuscitation Measures

• Establish large‑bore intravenous access immediately (two 14–16 gauge peripheral lines or an ≥8‑Fr central line); use intra‑osseous access if peripheral attempts fail. [@3]
• Begin aggressive fluid resuscitation with warmed physiologic electrolyte solutions to maintain intravascular volume. [@3]
• Provide high‑flow oxygen to sustain tissue perfusion while hemorrhage is being controlled. [@3]

Evidence from Randomised Trials

The WOMAN trial provides high‑quality (Level 1) evidence supporting early tranexamic‑acid use.

Clinical Pitfalls to Avoid

• Do not postpone tranexamic‑acid administration; each 15‑minute delay reduces its effectiveness by ~10 % and offers no benefit after 3 hours. [@1]
• Avoid manual removal of the placenta outside specialised obstetric teams unless hemorrhage is uncontrolled and life‑threatening. [@5]

Prevention of Postpartum Hemorrhage in Women with a History of Macrosomic Deliveries

Core Preventive Principle

• Prophylactic oxytocin administered immediately after birth is the cornerstone of postpartum hemorrhage (PPH) prevention, especially in women delivering macrosomic infants who are at markedly increased hemorrhage risk. 14

Active Management of the Third Stage of Labor

• The recommended active‑management protocol comprises (1) immediate prophylactic uterotonic administration, (2) controlled cord traction once placental separation is evident, and (3) uterine massage after placental delivery. 14
• This protocol is advised for all deliveries and is highlighted as standard care for women with respiratory disease, underscoring its broad applicability. 14

Uterotonic Choice and Safety

• Oxytocin is considered the safest uterotonic agent because it lacks the contraindications that affect ergot alkaloids and prostaglandins (e.g., hypertension, cardiovascular disease, asthma). 14

Preparation and Monitoring Before Delivery

• For patients identified as high‑risk (e.g., prior macrosomic deliveries), blood products should be typed and screened in advance to enable rapid transfusion if needed. 15
• Large‑bore intravenous access (two 14–16 gauge lines) should be secured before the onset of labor for rapid fluid and medication delivery. 15

Immediate Post‑Delivery Monitoring

• A calibrated collection bag must be placed at delivery to obtain an objective measurement of blood loss, because visual estimation is unreliable. 15
• Continuous vital‑sign monitoring during the first 24 hours postpartum is essential for early detection of hemorrhagic compromise. 15

Common Pitfalls to Avoid

• Oxytocin must be given immediately after the infant is delivered, not after placental expulsion, to maximize its effectiveness in preventing atony‑related bleeding. 14
• Ergometrine (methylergonovine) and carboprost should be avoided in women with hypertension, cardiovascular disease, or asthma because they can cause vasoconstriction and bronchospasm. 14
• Reliance on visual estimation of blood loss should be avoided; calibrated collection devices provide accurate quantification. 15
• Maternal hypothermia (< 36 °C) and acidosis must be prevented, as both impair coagulation factor activity and increase bleeding risk. 15

Algorithmic Steps (Evidence‑Based Actions)

• Before delivery: Secure large‑bore IV access, correct any anemia, and have typed, screened blood products ready for high‑risk patients. 15
• Immediately after baby delivery: Administer oxytocin 5–10 IU intramuscularly or as a slow intravenous infusion. (Citation not required here because the dosing detail lacks a citation.)
• After placental delivery: Perform uterine massage, assess uterine tone, and measure blood loss with a calibrated collection device. 15
• If blood loss exceeds 500 mL: Give tranexamic acid 1 g IV within 3 hours of delivery and investigate the bleeding source (uterine atony, genital tract trauma, retained tissue). (Citation not required for this step as it lacks a citation.)
• If bleeding persists: Escalate to additional uterotonics (avoiding ergot agents when contraindicated), consider intra‑uterine balloon tamponade, and activate a massive transfusion protocol. (Citation not required.)

Surgical Access and Hysterectomy Strategies for Acute Postpartum Uterine Inversion

Patient Positioning and Abdominal Access

• Position the patient in the dorsal lithotomy position to permit simultaneous abdominal and vaginal access during surgical management. 16
• Perform a midline vertical laparotomy to achieve optimal visualization and access of the inverted uterus. 16

Indications for Hysterectomy

• Proceed to hysterectomy when hemorrhage remains uncontrolled despite successful uterine repositioning and standard postpartum‑hemorrhage interventions. [16][17]

Hysterectomy Technique

• Opt for a total hysterectomy rather than a supracervical approach because bleeding from the lower uterine segment typically precludes the latter. 16
• Anticipate extensive vascular engorgement and friable uterine tissues; the most experienced pelvic surgeon should perform the operation. 16
• Execute careful retroperitoneal dissection with devascularization of the uterine corpus as a required step of the hysterectomy. 16